Clinical studies demonstrate significantly elevated serum levels of Ang II (28–31), matrix metalloproteinase-9 (MMP-9) (28), and monocyte chemoattractant protein-1 (MCP-1) (29) in AAD patients with ALI compared to controls and non-ALI AAD cases. This evidence concerns the gene AGT and acute respiratory distress syndrome.